.

Pharmaceutical Business Intelligence

  • Find generic sources and suppliers
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

DrugPatentWatch Database Preview

ASTELIN Drug Profile

« Back to Dashboard

Which patents cover Astelin, and what substitute generic drugs are available?

Astelin is a drug marketed by Meda Pharms and is included in one NDA.

The generic ingredient in ASTELIN is azelastine hydrochloride. There are twelve drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the azelastine hydrochloride profile page.

Summary for Tradename: ASTELIN

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list3
Bulk Api Vendors: see list37
Clinical Trials: see list4
Patent Applications: see list3,608
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ASTELIN at DailyMed

Pharmacology for Tradename: ASTELIN

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Meda Pharms
ASTELIN
azelastine hydrochloride
SPRAY, METERED;NASAL020114-001Nov 1, 1996RXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ASTELIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Meda Pharms
ASTELIN
azelastine hydrochloride
SPRAY, METERED;NASAL020114-001Nov 1, 19965,164,194*PED► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: ASTELIN

Drugname Dosage Strength RLD Submissiondate
azelastine hydrochlorideNasal Spray0.125 mg base/sprayAstelin11/14/2005
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc